IPSEN (EPA:IPN) Ipsen receives CHMP negative opinion, following re-examination of potential first FOP treatment in the E.U.
Directive transparence : information réglementée
26/05/2023 14:20
31/05/2023 18:04
31/05/2023 18:04
26/05/2023 14:20
26/05/2023 14:20
10/05/2023 14:00
10/05/2023 14:00
06/04/2023 19:04
06/04/2023 19:04
10/03/2023 18:00
10/03/2023 18:00